Clinical Trials Directory

Trials / Completed

CompletedNCT01286805

Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
83 (actual)
Sponsor
Hospital for Special Surgery, New York · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the use of a lumbar plexus block for arthroscopic hip surgery is superior to oral and intravenous opioid pain medications alone in treating pain. In addition, the study will examine whether lumbar plexus blocks reduce the total amount of pain medication needed, and therefore reduce the side effects of these medicines and increase patient satisfaction. It is hypothesized that addition of the lumbar plexus block will significantly reduce patients' postoperative pain.

Conditions

Interventions

TypeNameDescription
PROCEDURELumbar Plexus BlockadeThe lumbar plexus block will be dosed with 30 milliliters of 0.25% bupivacaine with 1:200,000 epinephrine
PROCEDUREControlThe control group will receive only a combined spinal-epidural.

Timeline

Start date
2010-05-01
Primary completion
2010-10-01
Completion
2011-05-01
First posted
2011-01-31
Last updated
2013-06-05
Results posted
2013-06-05

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01286805. Inclusion in this directory is not an endorsement.

Lumbar Plexus Block for Postoperative Pain Control After Hip Arthroscopy. A Randomized Controlled Trial (NCT01286805) · Clinical Trials Directory